论文部分内容阅读
通过口服或鼻腔粘膜给予乙酰胆碱受体可预防实验性自身免疫性重症肌无力模型的发生或治疗已经发生的肌无力 ,机制与调节细胞因子网络有关。自身耐受的研究可能为临床上治疗重症肌无力开辟一条新的和安全有效的途经。
Administration of acetylcholine receptors via the oral or nasal mucosa can prevent the development of experimental autoimmune myasthenia gravis or treat the development of myasthenia gravis, a mechanism that is involved in the regulation of the cytokine network. Self-tolerant research may open a new and safe and effective way for the clinical treatment of myasthenia gravis.